ESC Professional Premium Access

The impact of extensive ablation strategy for persistent atrial fibrillation on left atrial function and cardiovascular events: Insights from EARNEST-PVI randomized controlled trial

Congress Presentation

About the speaker

Doctor Takafumi Oka

Osaka University Graduate School of Medicine, Suita (Japan)
1 follower

8 more presentations in this session

Optimal cutoff duration of history or persistence of atrial fibrillation to undergo radiofrequency catheter ablation of longstanding atrial fibrillation

Speaker: Doctor Y. Egami (Sakai, JP)

Thumbnail

New mapping for determination of left atrial posterior wall isolation for non-paroxysmal atrial fibrillation

Speaker: Doctor A. Suzuki (Tokyo, JP)

Thumbnail

Empirical Marshall vein ethanol infusion as the first-line strategy in patients with persistent atrial fibrillation undergoing mitral isthmus ablation

Speaker: Doctor X. Du (Ningbo, CN)

Thumbnail

Acute termination as an endpoint in individualised electrophysiological substrate ablation in persistent atrial fibrillation

Speaker: Doctor A. Sharp (Oxford, GB)

Thumbnail

Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients

Speaker: Doctor M. Yano (Sakai, JP)

Thumbnail

Access the full session

Insights into catheter ablation of non-paroxysmal atrial fibrillation

Speakers: Doctor T. Oka, Doctor Y. Egami, Doctor A. Suzuki, Doctor X. Du, Doctor A. Sharp...
Thumbnail

About the event

Image

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

ESC 365 is supported by